Sellas Life Sciences Group, Inc. · NASDAQ:SLS
Vanguard Capital Management LLC reported a 5.19% stake in Sellas Life Sciences Group, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.19% stake in Sellas Life Sciences Group, Inc., 9,666,278 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.19%
- Shares
- 9,666,278
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.19% | 9,666,278 |
Source
Related
- Sellas Life Sciences Group, Inc.
- Vanguard Capital Management LLC
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026